Published in Pharmacol Rev on June 01, 1970
Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med (1973) 2.10
Network of immune-neuroendocrine interactions. Clin Exp Immunol (1977) 1.55
Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect Immun (1976) 1.35
Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol (2007) 1.11
Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect Immun (1979) 1.02
Brain lysosomal glycosidase activity in immunosuppressed mice infected with avirulent Semliki forest virus. Infect Immun (1977) 0.98
Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro. Clin Exp Immunol (1973) 0.97
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol (1975) 0.89
Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management. J Investig Med High Impact Case Rep (2013) 0.85
Differential effect of azathioprine on theta-antigenicity of mouse lymphocytes. Immunology (1974) 0.85
Macrophage dependence of polyriboinosinic acid-polyribocytidylic acid-induced resistance to herpes simplex virus infection in mice. Infect Immun (1980) 0.84
Cyclophosphamide-like cellular immunostimulation induced by 6-thioguanine (Lanvis). Immunology (1978) 0.80
Kinetics of antibody production by single cells. II. The action of transcription and translation inhibitors upon the metabolism of haemolysin-secreting cells. Immunology (1972) 0.79
Immunosuppression by hydroxystilbamidine isethionate, a lysosome-stabilizing, anti-proteolytic, antifungal drug. Infect Immun (1975) 0.78
Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs. J Clin Invest (1975) 0.77
Late immune and haemopoietic functions in plasmacytoma-bearing mice cured by melphalan. Br J Cancer (1988) 0.75
Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma. J Clin Invest (1977) 0.75
Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat. J Clin Invest (1982) 0.75
Enhancement and inhibition of immunological mechanisms by immunosuppressive agents. I. Dose effect on priming and generation of memory to a bacterial antigen. Clin Exp Immunol (1978) 0.75
Modulation of the immune system in the mouse. 2. Drug administration following antigen sensitization. Agents Actions (1980) 0.75
Effect of the antitumor antibiotic chromomycin A3 on the humoral immune response in rats. Infect Immun (1975) 0.75
Problems with immunosuppressive agents in renal disease. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75
Effects of cortisone on H-2 agglutinin response in normal and thymectomized adult mice. Immunology (1973) 0.75
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
The SENIEUR Protocol after 16 years: a need for a paradigm shift? Mech Ageing Dev (2001) 4.28
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
Age influence on the immune system. Adv Immunol (1980) 2.74
Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47
Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc (1967) 2.44
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]. Anal Biochem (1979) 2.19
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
Immunologic deficiencies in senescence. I. Characterization of intrinsic deficiencies. J Immunol (1972) 1.88
The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol (1973) 1.78
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Cyclosporin A and the thymus. Immunopathology. Am J Pathol (1987) 1.65
Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64
Growth and senescence of antibody-forming cells. J Cell Physiol (1966) 1.58
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
Secondary antibody-forming potential of mice in relation to age--its significance in senescence. Dev Biol (1966) 1.55
The suppressive effect of supraoptimum doses of antigen on the secondary antibody-forming response of spleen cells cultured in cell-impermeable diffusion chambers. J Immunol (1965) 1.54
Effects of aging on the differentiation and proliferation potentials of cells of the immune system. Fed Proc (1975) 1.53
Proliferative and differentiative manifestations of cellular immune potential. Prog Allergy (1967) 1.53
Immunologic deficiencies in senescence. II. Characterization of extrinsic deficiencies. J Immunol (1972) 1.53
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Immunologicc activity of the aged. Adv Gerontol Res (1971) 1.44
Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med (1985) 1.44
Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell. J Immunol (1981) 1.41
Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med (1983) 1.41
Decline in the growth potential of spleen-colonizing bone marrow stem cells of long-lived aging mice. J Exp Med (1976) 1.41
Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science (1984) 1.39
Clinical toxicity of cryopreserved bone marrow graft infusion. Blood (1990) 1.38
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis (1984) 1.37
Sequential morphology of graft-versus-host disease in the rat radiation chimera. Clin Immunol Immunopathol (1982) 1.33
Synthesis of antibody by spleen cells after exposure to kiloroentgen doses of ionizing radiation. J Cell Physiol (1967) 1.28
Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol (1987) 1.26
Single-dose pharmacokinetics of acyclovir. Antimicrob Agents Chemother (1981) 1.23
Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine (Baltimore) (1988) 1.22
Recruitment and proliferation of immunocompetent cells during the log phase of the primary antibody response. J Immunol (1969) 1.20
A model for the interaction of cell types in the generation of hemolytic plaque-forming cells. J Immunol (1970) 1.18
Host repopulation of endothelium. Transplant Proc (1971) 1.16
Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood (1991) 1.16
Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood (1988) 1.16
Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. JAMA (1988) 1.15
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med (1986) 1.14
Suppression of immunologic responses. Med Clin North Am (1965) 1.14
Herpes zoster infection after autologous bone marrow transplantation. Blood (1989) 1.12
Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet (1989) 1.11
The effect of cytotoxic drugs on graft-versus-host disease in mice. Transplantation (1971) 1.11
19S and 17S antibody production in the cyclophosphamide- or methotrexate-treated rat. Nature (1966) 1.11
Influence of age on the production and regulation of interleukin-1 in mice. Immunology (1985) 1.11
Further studies on the secondary antibody-forming potential of juvenile, young adult, adult, and aged mice. Dev Biol (1966) 1.10
THE IMMUNE STATUS OF LONG-TERM SURVIVORS OF LETHALLY X-IRRADIATED MICE PROTECTED WITH ISOLOGOUS, HOMOLOGOUS, OR HETEROLOGOUS BONE MARROW. Proc Natl Acad Sci U S A (1958) 1.10
Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med (1978) 1.09
Effect of age on cell-mediated immunity in long-lived mice. Clin Exp Immunol (1975) 1.09
Immunologic basis for susceptibility to infection in the aged. Gerontology (1984) 1.08
The immune systems of mice reared in clean and in dirty conventional laboratory farms. I. Life expectancy and pathology of mice with long life-spans. J Gerontol (1971) 1.08
Age-associated changes in the DNA of mouse tissue. Science (1971) 1.07
The pathology of the graft-versus-host reaction (GVHR) in adults receiving bone marrow transplants. Transplant Proc (1976) 1.06
Immunobiology of aging: evaluation of current status. Clin Immunol Immunopathol (1976) 1.06
Presence of impairment of humoral immunity in nonadherent spleen cells of old mice. J Immunol (1973) 1.05
Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood (1980) 1.05
Development of immunologic competence in germfree and conventional mice. J Immunol (1967) 1.05
Regenerative potential of immunocompetent cells. I. Lack of recovery of secondary antibody-forming potential after x-irradiation. J Immunol (1967) 1.05
Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia. Science (1972) 1.05
The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol (1983) 1.05
Stochastic model for the production of antibody-forming cells. Nature (1969) 1.04
Humoral immunity in aging. Fed Proc (1974) 1.02
Further characterization of the lymphoid cell transfer system for the study of antigen-sensitive progenitor cells. J Immunol (1968) 1.01
Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis. Transplant Proc (1976) 1.01
Marrow transplanation in man following cyclophosphamide. Transplant Proc (1971) 1.01
An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med (1985) 1.01
Graft-versus-host reactions and disease. Immunol Rev (1985) 1.01
Growth patterns of antibody-forming cell populations. Curr Top Microbiol Immunol (1969) 1.00
Antitheta-sensitive regulatory cell (TSRC) and hematopoiesis: regulation of differentiation of transplanted stem cells in W/Wv anemic and normal mice. Blood (1978) 1.00
Role of T cells and adherent cells in age-related decline in murine interleukin 2 production. J Immunol (1982) 1.00
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers. Drug Metab Dispos (1989) 0.99
Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. J Clin Microbiol (1985) 0.99
Immunological changes in young and old adults during brief laboratory stress. Psychosom Med (1991) 0.99
Functional MRI as a tool to assess vision in dogs: the optimal anesthetic. Vet Ophthalmol (2001) 0.98
Reduced humoral immune activity in long-lived old mice: an approach to elucidating its mechanisms. Immunology (1976) 0.98
Mechanism of senescence of immune response: introductory remarks. Fed Proc (1978) 0.98
Thymic involution: effect on T cell differentiation. J Immunol (1975) 0.98
Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras. Transplantation (1981) 0.97
Significance of a single-hit event in the initiation of antibody response. Nature (1966) 0.96
Differential assay of zidovudine and its glucuronide metabolite in serum and urine with a radioimmunoassay kit. Clin Chem (1990) 0.96
Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol (1989) 0.95
Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia. J Natl Cancer Inst (1974) 0.95
Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant (1987) 0.94
B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation. Transplantation (1982) 0.94
Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant Proc (1969) 0.94